In September 1995, the FDA at first permitted testosterone transdermal patches (Androderm); a lot of transdermal varieties and brands are now readily available like implants, gels, and topical remedies. A testosterone buccal program, Striant, was FDA authorized in July 2003; the system is a mucoadhesive item that adheres to the buccal mucosa and pr